News

Categories
Sign up
Featured Posts
Archive
Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

The Birth of Alpha Tau Medical – the Medicine Researcher Perspective

Cancer is the most devastating chronic disease affecting humankind. More than 1 out of 3 people in the United States will have cancer during their lifetimes, of which 30% of them will die 5 years from diagnosis [i]. As people live longer, the number of new cancer cases set to nearly double by the year 2050 [i]. For those who survive, existing treatments can lead to severe cancer side effects in many cases, resulting in significant negative impact on quality of life. Consequently, there is a great need for effective treatments that maintain patient’s quality of life. Alpha Tau’s development of the first alpha-radiation-based cancer treatment for various types of solid tumors provides us with

Alpha Tau

Looking for clinical trials?

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon